جست‌وجوی استاد و پژوهشگر

Helen Suhمشاهده پروفایل

استاد

• Environmental Health
• Environmental Epidemiology
• Air Pollution
• +۲ مورد دیگر

Helen Suh is a Professor at Tufts University, jointly appointed in the departments of Civil and Environmental Engineering and Community Health . As an internationally-recognized expert in air pollution health effects, she combines environmental epidemiology , exposure science , and data analytics to investigate how pollutants impact human health. Sc.D. , Harvard University (1993) M.S. , Harvard University (1990) S.B. , Massachusetts Institute of Technology (1985) Her research focuses on three areas: air pollutant impacts on cognitive performance and child development , multi-pollutant health effects , and GIS-based spatio-temporal modeling for epidemiological studies. Recent publications highlight her work on PM2.5 measurement error correction , hormonal disruptions in pregnancy , and machine learning applications in environmental health analysis. Current trends include: Advanced statistical methods for exposure assessment Multi-omics approaches to cardiometabolic health International comparative studies (e.g., Tehran, Puerto Rico) Long-term mortality analysis in Medicare populations Pollution-immune system interactions in vulnerable groups Policy-relevant modeling for air quality standards Helen Suh has served as an Associate Editor for the Journal of Exposure Science and Environmental Epidemiology and advised major U.S. and international health organizations. Her work spans over 150 publications and integrates multidisciplinary team leadership in environmental health science. Her laboratory develops large-scale data analytics tools and spatio-temporal exposure models to support population-level health research. Current projects include air pollution and aging cohorts , urban environmental noise measurement , and epigenetic responses to pollutants .

• Pharmacokinetics
• Pharmacodynamics
• Model-Informed Drug Development
• +۴ مورد دیگر

Guohua An, MD, PhD, is an Associate Professor in the Department of Pharmaceutical Sciences and Experimental Therapeutics at the University of Iowa College of Pharmacy. She holds expertise in mechanistic pharmacokinetic/pharmacodynamic (PK/PD) modeling, population PK in special populations, model-informed drug development, and quantitative systems pharmacology. Her research focuses on optimizing drug therapies for critically ill patients, infants, and surgical patients, with emphasis on antibiotics and novel drug candidates like HSD-1 inhibitors. Dr. An has a dual background in clinical pharmacy and pharmaceutical sciences, with industry experience at AbbVie and prior academic roles at the University of Florida. Education: MS in Clinical Pharmacology, Fudan University, China PhD in Pharmaceutical Sciences, SUNY University at Buffalo, USA Research Interests: Dr. An’s work integrates PK/PD modeling to inform drug development and clinical care, particularly in special populations. She explores mechanisms of drug disposition, target-mediated effects, and systems pharmacology to enhance therapeutic outcomes. Her recent studies address empiric dosing strategies for antibiotics (e.g., piperacillin-tazobactam), nonlinear pharmacokinetics of inhibitors, and quantitative models for incretin hormones. Publications: Her articles emphasize PK/PD modeling in antibiotics, HSD-1 inhibitors, and siRNA therapeutics. Key themes include population pharmacokinetics in cystic fibrosis patients, target-mediated drug disposition, and systems pharmacology approaches to diabetes therapies. Labs/Teams: Collaborates with interdisciplinary teams in clinical pharmacology and drug development, leveraging both academic and industrial partnerships.

Kimberly Keil Stietzمشاهده پروفایل

استادیار

• Environmental Toxicology
• Neurotoxicology
• Urology
• +۴ مورد دیگر

Kimberly Keil Stietz is an Assistant Professor in the Department of Comparative Biosciences at the University of Wisconsin-Madison School of Veterinary Medicine. Her research focuses on environmental toxicology, neurotoxicology, and urology, particularly examining how developmental exposure to polychlorinated biphenyls (PCBs) affects urinary function. Education: B.S. in Biology, St. Norbert College (2010) Ph.D. in Comparative Biosciences, University of Wisconsin-Madison (2014) Postdoctoral research in neurotoxicology, University of California-Davis (2015-2019) Stietz's lab investigates the effects of environmental contaminants on the lower urinary tract, emphasizing PCB exposure during development. Using in vitro and in vivo mouse models, the lab studies disruptions in bladder epithelium organization, nerve fiber patterning, inflammation, and peripheral-central nervous system crosstalk. Key projects include analyzing PCB impacts on bladder barrier function, innervation patterns, inflammatory responses, and dorsal root ganglia signaling. Recent publications highlight her work on PCB effects across multiple domains: adult female bladder contractility (2023), prostatic collagen changes (2023), machine learning-aided metabolite analysis (2023, 2022), and developmental PCB exposure links to voiding physiology (2022). Her 2021 studies explored behavioral phenotypes in PCB-exposed mice, dendritic effects, and bladder inflammation, while 2019 work included host-microbe interactions and open-source uroflowmetry tools.

Tiffany K. Horمشاهده پروفایل

استادیار

• Endocrinology
• Diabetes
• Metabolism
• +۴ مورد دیگر

Tiffany K. Hor, MD, is an Assistant Professor in the Department of Internal Medicine at Rush Medical College, Rush University, Chicago, IL. She is a board-certified endocrinologist with clinical expertise in diabetes, thyroid disease, pituitary disorders, and ultrasound-guided thyroid procedures. Her research focuses on clinical endocrinology, particularly diabetes management in both outpatient and inpatient settings. Key areas include insulin therapy optimization, post-bariatric hypoglycemia, and complications of thyroid interventions. Her scholarly work reflects a strong emphasis on practical clinical applications and patient safety. Dr. Hor's publications highlight trends in insulin regimens, rare endocrine complications, and innovative uses of high-concentration insulin. Her work bridges clinical practice and research to improve patient outcomes in complex endocrine disorders. Endocrinology, Diabetes and Metabolism – Board Certification She has contributed to clinical research through publications in journals such as Journal of Clinical Endocrinology & Metabolism , Thyroid , and Case Reports in Endocrinology . Her work includes clinical trials and case studies that inform evidence-based practice in endocrinology. Dr. Hor is actively involved in patient care at Rush Endocrinology, located at 1725 W. Harrison St., Suite 250, Chicago, IL. She mentors trainees and contributes to medical education at Rush Medical College. There is no information available about formal advisees or research grants.

• Neuropharmacology
• Neuroendocrinology
• Sleep Research
• +۳ مورد دیگر

Jessica A. Mong, PhD , is a Professor in the Department of Pharmacology & Physiology at the University of Maryland School of Medicine , where she also serves as Assistant Dean for Graduate & Post-Doctoral Studies and Director of Graduate Education for the Program in Neuroscience. Her research focuses on the neuroendocrine mechanisms underlying sex differences in sleep circuitry and the estrogenic modulation of sleep-wake cycles. Primary Appointment: Pharmacology & Physiology Administrative Title: Assistant Dean for Graduate & Post-Doctoral Studies Laboratory Director: Program in Neuroscience Research Interests: Dr. Mong's work investigates how ovarian steroids influence sleep-wake behavior through sexually differentiated neuroanatomical substrates. Key areas include: Mechanisms of estrogenic modulation in the median preoptic nucleus (MnPN) Developmental programming of sex differences in sleep sensitivity Translational studies using rodent and nonhuman primate models of menopause Functional significance of hormonal influences on sleep quality and recovery Scientific Trends: Her recent publications (2023-2025) emphasize: Role of KCNMA1 channelopathy in sleep regulation Adenosinergic signaling in MnPN Translational menopause models Estrogen's protective effects against noise-induced hearing loss Sex-dependent responses to kynurenine pathway challenges Awards & Appointments: NIH BIRCWH Scholar (Building Interdisciplinary Research Careers in Women's Health) Co-Chair, Society for Women’s Health Research Interdisciplinary Research Network on Sex-Differences in Sleep Health NIH/NHLBI R01 HL129138 grant recipient Education & Training: B.S., Biology, Gettysburg College (1987-1991) Ph.D., Neuropharmacology, University of Maryland Baltimore (1994-2000) NIH Postdoctoral Fellowship in Endocrinology, Rockefeller University (2000-2003)

Andrew Godwinمشاهده پروفایل

استاد

• Molecular Oncology
• Precision Medicine
• Biomarker Discovery
• +۳ مورد دیگر

Andrew Godwin is a Professor at the University of Kansas Medical Center , where he serves as the Chancellor’s Distinguished Chair in Biomedical Sciences and Director of Molecular Oncology in the Department of Pathology and Laboratory Medicine. He is also the Deputy Director of the NCI-designated University of Kansas Cancer Center and the Founding Director of the Kansas Institute for Precision Medicine and Biospecimen Shared Resource . Dr. Godwin is a leader in translational research and precision medicine , with a focus on molecular oncology , biomarker discovery , and genomic diagnostics . His work bridges basic and clinical science to improve cancer patient care, particularly in ovarian cancer , Ewing sarcoma , and breast cancer . He has contributed over 230 ovarian cancer-related publications and pioneered studies linking the PI3K/AKT pathway to cancer treatment targets. His research program encompasses liquid biopsies using extracellular vesicles , molecular therapeutics , companion diagnostics , and clinical trial validation . He leads the Biomarker Discovery Laboratory and has secured over $250M in extramural funding , including a $11.4M NIH grant for precision medicine initiatives. His team has developed CELLSEARCH® , the first FDA-cleared test for circulating tumor cells. Notable awards include the Dolph C. Simons, Sr. Higuchi Award (2020), Outstanding Mentorship in Pathology Award (2024), and multiple mentoring accolades from KU. He has mentored over 150 trainees across career stages and leads a multidisciplinary lab with expertise in genomics , proteomics , and bioengineering . Academic Roles: Chancellor’s Distinguished Chair in Biomedical Sciences Director, Molecular Oncology, Pathology and Laboratory Medicine Deputy Director, KU Cancer Center Founding Director, Kansas Institute for Precision Medicine Adjunct Professor, Bioengineering Program, University of Kansas Scientific Awards: KUMC Achievement Award for mentoring postdocs (2014) Chancellor’s Club Award for Research (2018) Dolph C. Simons, Sr. Higuchi Award (2020) KU Excellence in Mentoring Award (2021) Outstanding Mentorship in Pathology (2024) Key Research Themes: Extracellular vesicles as liquid biopsy tools Molecular mechanisms of sarcoma and breast cancer Genomic diagnostics and precision oncology Clinical trial biomarker validation Biospecimen repository leadership

• Oxygen Transport
• Vascular Physiology
• Skeletal Muscle Metabolism
• +۳ مورد دیگر

Russell Richardson is a tenured Professor at the University of Utah , holding joint appointments in the Department of Internal Medicine (Division of Geriatrics) and the Department of Exercise and Sport Science . He directs the Utah Vascular Research Laboratory (UVRL) at the Salt Lake VA Medical Center. Education: Fellowship (University of California San Diego), Doctoral Training (University of Utah), PhD (Colorado State University), MS (Loughborough University), PGCE (West London Institute of Higher Education) His research focuses on oxygen transport from air to tissue , with a current emphasis on the link between vascular and skeletal muscle function , particularly how oxidative stress regulates skeletal muscle metabolism and vascular control. He has authored numerous studies on aging, vascular dysfunction, and exercise hemodynamics. Recent publications highlight work on mitochondrial respiration, passive limb movement techniques, antioxidant interventions, and age-related vascular decline. His lab employs both in vivo and ex vivo methodologies to investigate these mechanisms. Collaborations span clinical and physiological domains, including studies in chronic obstructive pulmonary disease (COPD), heart failure, and breast cancer. His work integrates gerontology , exercise physiology , and vascular biology . Notable affiliations include the Salt Lake VA Medical Center and contributions to understanding the interplay between physical activity, aging, and vascular plasticity.

• Autism Genetics
• Genetic Architecture
• Copy Number Variants
• +۵ مورد دیگر

Lauren Weiss, PhD is a Professor of Psychiatry at the University of California, San Francisco (UCSF) School of Medicine and a faculty member at the UCSF Weill Institute for Neurosciences. Her research focuses on understanding the genetic architecture of autism spectrum disorder through genome-wide genetic data analysis and human induced pluripotent stem cell (iPSC) models. Dr. Weiss's laboratory investigates the genetic mechanisms by which DNA variants influence autism risk, examining questions about copy number vs. SNP variation, rare vs. common variation, gene-sex interaction, gene-gene interaction, and gene-environment interaction. Her team uses rich genetic datasets to identify susceptibility loci and the physiological pathways these risk loci implicate. Additionally, they employ iPSC models to study known mutations or copy number variants predisposing to autism, first identifying the effects of genetic risk variants and then determining whether these effects can be modified at the cellular level by environmental or pharmacological agents. Analysis of Dr. Weiss's recent publications reveals a strong focus on sex differences in autism genetics, the role of specific copy number variants (particularly 16p11.2 and 22q11.2), maternal environmental factors during pregnancy, and the integration of multi-omics data to understand neurodevelopmental pathways. Her work bridges basic genetic research with potential clinical applications for improving understanding, prevention, diagnosis, and treatment of autism and related traits. Dr. Weiss has secured significant research funding as Principal Investigator on multiple NIH grants, including R01MH114924 (Decoding the Genetics of Sexual Dimorphism in Autism Spectrum Disorders), R01MH107467 (Utilizing eQTL networks to gain biological insight into multigenic CNVs), and DP2OD007449 (Dissecting Epistasis and Pleiotropy in Autism towards Personalized Medicine). Her laboratory offers research opportunities for students interested in analytical genetics projects related to gene-environment effects, gene-sex effects, gene-gene effects, and the relationship between ASD and brain size. Dr. Weiss actively collaborates with numerous researchers across institutions, particularly on large-scale genomic studies of autism and other neurodevelopmental disorders. Her work has contributed significantly to our understanding of the complex genetic architecture underlying autism spectrum disorder and related conditions.

Dimitrios Anastasiouمشاهده پروفایل

استاد پژوهشی

• Cancer Metabolism
• Metabolic Reprogramming
• Biochemistry & Proteomics
• +۳ مورد دیگر

Dimitrios (Dimitris) Anastasiou is a Senior Group Leader at The Francis Crick Institute in London, UK, specializing in cancer metabolism research. Previously, he served as a Group Leader at the Medical Research Council National Institute for Medical Research (NIMR) starting in 2012 before transitioning to the Crick Institute in 2015. His research career includes postdoctoral work and an Instructor position at Beth Israel Deaconess Medical Center and the Department of Systems Biology, Harvard Medical School under Lewis Cantley, where he focused on metabolic reprogramming in cancer. University College London, UK - BSc Molecular Biology (2001) University of Basel, Basel, Switzerland - PhD in Biochemistry (2006) Anastasiou's research centers on understanding how cancer cells generate energy and utilize nutrients differently from normal cells. His laboratory conducts detailed analyses of metabolic pathways in cancer, investigating how tumor cells rewire their metabolism to support rapid growth and evade the body's defenses. His work spans biochemistry, proteomics, computational systems biology, human physiology, and tumor biology, with particular emphasis on identifying metabolic vulnerabilities that could be targeted for cancer therapy. His innovative approaches include developing chemical 'sensors' to monitor metabolic changes in cancer cells over time as tumors develop. Analysis of his recent publications reveals a consistent focus on metabolic regulation in cancer, particularly regarding glycolysis, hypoxia response, amino acid metabolism, and nucleotide biosynthesis. His work frequently examines enzyme regulation (particularly PKM2), metabolic adaptation to environmental stressors, and the intersection between metabolism and signaling pathways. A notable trend is his exploration of how metabolic enzymes function beyond their traditional roles, influencing cellular signaling and gene expression in cancer contexts. Anastasiou has made significant contributions to understanding metabolic reprogramming in cancer, particularly regarding pyruvate kinase M2 regulation, hypoxia responses, and nutrient utilization in tumor microenvironments. His work bridges basic biochemical mechanisms with potential therapeutic applications, focusing on identifying metabolic vulnerabilities in cancer cells that could be exploited for treatment. As a Senior Group Leader at the Crick Institute, Anastasiou leads a research group investigating how metabolism contributes to disease, particularly cancer. His laboratory utilizes a range of techniques including metabolomics, bioinformatics, structural biology, and high-throughput screening to study metabolic pathways. The group's work aims to identify fundamental differences between metabolic pathways in tumors and healthy tissue to discover new therapeutic targets against cancer.

Catherine Marlerمشاهده پروفایل

استاد

• Behavioral Neuroendocrinology
• Animal Behavior
• Social Neuroscience
• +۷ مورد دیگر

Catherine Marler is a Professor in the Department of Psychology at the University of Wisconsin-Madison, where she leads the Marler Lab focused on the Biology of Brain and Behavior. Her research program investigates the intricate connections between endocrine systems and social behaviors, with particular emphasis on how hormones like testosterone and oxytocin shape complex social interactions in monogamous mammals. Dr. Marler's research primarily utilizes the California mouse (Peromyscus californicus) as a model organism, capitalizing on its unique monogamous, biparental, and territorial nature. Her work spans both laboratory and field settings, allowing for comprehensive investigation of neuroendocrine mechanisms in naturalistic contexts. Key research themes include the role of testosterone in territorial behavior and winner effects, oxytocin's influence on pair bonding and parental behavior, and the neural substrates of ultrasonic vocalizations. Recent publications reveal a strong focus on conditioned place preferences related to testosterone pulses, oxytocin's effects on social behaviors across different developmental stages, and the neuroendocrine mechanisms underlying aggression and pair bonding. Her work demonstrates how social experience, environmental context, and endocrine systems interact to shape complex behavioral outcomes, with particular attention to sex differences and transgenerational transmission of behaviors. Dr. Marler has published extensively in top journals including Hormones and Behavior, Proceedings of the Royal Society, and Animal Behaviour, with her most recent work appearing in high-impact venues throughout 2023-2025. Her research program represents a sophisticated integration of behavioral observation, endocrine manipulation, and neural analysis to unravel the mechanisms underlying social behavior in mammals. As an advisor, Dr. Marler mentors students in behavioral neuroscience and endocrinology, fostering research that bridges laboratory and field approaches to understand the evolution and mechanisms of social behavior. Her lab maintains a strong commitment to rigorous scientific methodology and innovative experimental design in the study of neuroendocrine-behavior relationships.

Nick Turnerمشاهده پروفایل

استاد

• Bioanalytical Chemistry
• Molecular Imprinting
• Biosensors
• +۴ مورد دیگر

Professor Nick Turner is a Professor in Bioanalytical Chemistry at the University of Sheffield's Department of Chemistry within the School of Mathematical and Physical Sciences. He holds a BSc in Pharmacology (University of Southampton, 1997), an MRes in Biochemistry (University of Exeter, 1999), and a PhD in Bio-organic Chemistry (Cranfield University, 2004). His career includes roles at the University of Utah, University of Newcastle (Australia), Open University, and De Montfort University, where he progressed from Lecturer to Reader in Bioanalytical Chemistry. In 2022, he received an EPSRC Established Career Fellowship for artificial chaperone research and was awarded a personal chair. His research focuses on molecular recognition, particularly molecularly imprinted polymers (MIPs) for biosensing, nucleic-acid-polymer hybrids, and artificial chaperones. These technologies address challenges in drug detection, environmental monitoring, and biomedical diagnostics. He actively supports PhD applications in these areas. Awards: EPSRC Established Career Fellowship (2022), Senior Fellowship of HEA (2016) Professional Memberships: Royal Society of Chemistry, Macro Group UK (Secretary) Teaching interests include analytical chemistry and pharmacology, emphasizing modern techniques like VR/AR in drug design education. He contributes to interdisciplinary projects such as the Open Science Laboratory and MOOC development.

Sachi Horibataمشاهده پروفایل

استادیار

• Cancer Biology
• Drug Discovery
• Computational Genomics
• +۳ مورد دیگر

Sachi Horibata is an Assistant Professor in the Department of Pharmacology & Toxicology at Michigan State University (MSU), affiliated with the College of Human Medicine. She is also associated with the Precision Health Program and the Neuroscience Program. Her research focuses on cancer biology, drug discovery, and computational genomics, with a particular emphasis on understanding mechanisms of drug resistance in cancers like acute myeloid leukemia (AML) and breast cancer. Dr. Horibata’s work integrates proteomics, transcriptomics, and cellular models to uncover therapeutic targets and biomarkers. She holds a PhD in Biological and Biomedical Sciences from Cornell University (2010–2016). Her research interests include genomic analysis of cancer heterogeneity, enzyme-driven cancer progression (e.g., PAD enzymes), and immune evasion mechanisms in tumors. Her recent studies highlight the role of protein citrullination in cancer cell migration and endocrine resistance. Dr. Horibata’s publications span topics in oncology, immunology, and molecular biology, with a focus on translational research. She teaches PHM 802: Cellular, Molecular and Integrated Systems Pharmacology. Her lab is located in the Interdisciplinary Science and Technology Building at MSU.

Xuesen Dongمشاهده پروفایل

دانشیار

• Prostate Cancer
• Cancer Therapy Resistance
• Cancer Progression and Metastasis
• +۷ مورد دیگر

Dr. Xuesen Dong is an Associate Professor in the Department of Urologic Sciences at the University of British Columbia and a senior scientist at the Vancouver Prostate Centre. His research focuses on prostate cancer therapy resistance mechanisms and developing novel therapeutics. His educational background: Medical training in China MSc in Molecular and Cellular Biology, Laval University PhD in Physiology, University of Toronto Postdoctoral training: Samuel Lunenfeld Research Institute (Mount Sinai Hospital, University of Toronto) and Vancouver Prostate Centre Research interests include prostate cancer, therapy resistance, RNA splicing, gene regulation, drug development, hormone-dependent cancers, endocrine regulation, and biomarker discovery. His lab uses RNA sequencing and computer-aided drug design to identify new targets and diagnostics for prostate cancer. Scientific awards and funding: Rising Star Award from Prostate Cancer Canada Continuously funded by Canadian Institutes of Health Research (CIHR) grants since 2005 Dr. Dong supervises graduate students in UBC's Cell and Developmental Biology, Experimental Medicine, and Interdisciplinary Oncology programs. His laboratory at the Vancouver Prostate Centre is dedicated to overcoming treatment resistance in prostate cancer.

Andreas Kortenkampمشاهده پروفایل

استاد

• Environmental Toxicology
• Mixture Toxicology
• Endocrine Disruptors
• +۳ مورد دیگر

Professor Andreas Kortenkamp is a leading academic in the field of Human Molecular Toxicology, affiliated with Brunel University's Department of Life Sciences within the College of Health, Medicine and Life Sciences. His research focuses on understanding combined effects of environmental pollutants, developing regulatory strategies for chemical mixtures, and studying hormonal carcinogenesis. Education and Career: Bachelor's in Chemistry, Philosophy, and Educational Sciences (University of Münster, 1983) PhD in Chemistry (University of Bremen, 1989) Post-doctoral Fellowships and academic roles at Queen Mary University of London and the School of Pharmacy, University of London (1990–2011) Since 2011, Professor at Brunel University's Institute for the Environment Research Interests: Mixture toxicology and predicting combined chemical effects Endocrine disruptors and their regulatory implications Hormonal mechanisms in breast cancer Impact of environmental chemicals on human and wildlife health Grants and Collaborations: EU-funded projects on endocrine disruptors and mixture toxicity Collaborations with institutions like the European Commission, WHO, and US National Academy of Sciences Contributions to policy decisions on chemical regulation Current Projects: State of the Art Assessment for Endocrine Disrupters (EU Commission) Research on semen quality decline linked to chemical mixtures Development of thyroid hormone disruption assays (ATHENA Project) Advising and Teams: Supervises PhD students in hormonal carcinogenesis and toxicology Leads research groups focused on environmental health and toxicology

Catherine Crockfordمشاهده پروفایل

استاد پژوهشی

• Primate Behavior
• Social Cognition
• Vocal Communication
• +۴ مورد دیگر

Dr. Catherine Crockford is Research Professor and Director of the Ape Social Mind Lab at the Max Planck Institute for Evolutionary Anthropology, affiliated with the Department of Human Behavior, Ecology and Culture. She co-directs the Tai Chimpanzee Project in Ivory Coast, studying habituated chimpanzee groups and sooty mangabeys. Her research examines primate social cognition, communication evolution, and neuroethology through behavioral observations, hormone sampling, and neuroimaging. Key interests include: Evolution of social bonding and cooperation mechanisms Maternal effects on offspring development Vocal communication and combinatorial signaling Neurobiological bases of social behavior Her publications demonstrate consistent focus on chimpanzee vocal combinatorics, stress physiology, social learning, and comparative neuroanatomy, often integrating field data with endocrine and imaging methodologies. She leads an ERC project investigating early-life influences on social skills and supervises 8 PhD students researching primate communication, social dynamics, and energetics. Laboratory infrastructure supports field endocrinology and collaborative neuroimaging studies.